Stay updated on Abbott Press Releases

Sign up to get notified when there's something new on the Abbott Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Abbott Press Releases page

  1. Check
    7 days ago
    Change Detected
    Summary
    Abbott has announced a conference call for its third-quarter earnings and declared its 403rd consecutive quarterly dividend, while recent news about a mixed reality technology study and the launch of a new weight loss brand have been removed.
    Difference
    13%
    Check dated 2024-09-25T22:32:42.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new survey from Abbott highlights that epidemiologists prioritize viral and mosquito-borne pathogens as key concerns for disease outbreaks, while a previous announcement about Abbott's rechargeable system for movement disorders has been removed.
    Difference
    8%
    Check dated 2024-09-18T16:41:49.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Abbott has launched its Lingo™ Continuous Glucose Monitor in the U.S. and initiated a clinical study for its Deep Brain Stimulation System to treat severe depression, while recent financial results and updates on a neurostimulation system have been removed.
    Difference
    15%
    Check dated 2024-09-11T07:45:41.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Abbott has expanded its Pure Bliss™ line of infant formulas to include organic options and introduced the first organic liquid formula available in U.S. retail, while also advancing heart failure management with a new aspirin-free regimen for HeartMate 3™ patients.
    Difference
    23%
    Check dated 2024-08-28T02:29:58.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Abbott has announced a significant global partnership to integrate its continuous glucose monitoring system with Medtronic's insulin delivery devices, while a previous earnings conference call has been removed from the site.
    Difference
    7%
    Check dated 2024-08-13T23:30:29.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Abbott has issued a voluntary medical device correction for a limited number of FreeStyle Libre® 3 Sensors in the U.S., while a previous announcement regarding their presentation at the J.P. Morgan Healthcare Conference has been removed.
    Difference
    7%
    Check dated 2024-07-25T17:25:06.000Z thumbnail image

Stay in the know with updates to Abbott Press Releases

Enter your email address, and we'll notify you when there's something new on the Abbott Press Releases page.